1. Home
  2. ARQT vs GEL Comparison

ARQT vs GEL Comparison

Compare ARQT & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • GEL
  • Stock Information
  • Founded
  • ARQT 2016
  • GEL 1996
  • Country
  • ARQT United States
  • GEL United States
  • Employees
  • ARQT N/A
  • GEL N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • GEL Oil Refining/Marketing
  • Sector
  • ARQT Health Care
  • GEL Energy
  • Exchange
  • ARQT Nasdaq
  • GEL Nasdaq
  • Market Cap
  • ARQT 1.7B
  • GEL 1.6B
  • IPO Year
  • ARQT 2020
  • GEL 1996
  • Fundamental
  • Price
  • ARQT $13.89
  • GEL $16.74
  • Analyst Decision
  • ARQT Strong Buy
  • GEL Buy
  • Analyst Count
  • ARQT 6
  • GEL 3
  • Target Price
  • ARQT $18.80
  • GEL $16.50
  • AVG Volume (30 Days)
  • ARQT 1.9M
  • GEL 642.1K
  • Earning Date
  • ARQT 08-13-2025
  • GEL 07-31-2025
  • Dividend Yield
  • ARQT N/A
  • GEL 3.94%
  • EPS Growth
  • ARQT N/A
  • GEL N/A
  • EPS
  • ARQT N/A
  • GEL N/A
  • Revenue
  • ARQT $212,819,000.00
  • GEL $2,930,080,000.00
  • Revenue This Year
  • ARQT $61.15
  • GEL N/A
  • Revenue Next Year
  • ARQT $37.98
  • GEL $5.69
  • P/E Ratio
  • ARQT N/A
  • GEL N/A
  • Revenue Growth
  • ARQT 100.03
  • GEL 3.87
  • 52 Week Low
  • ARQT $7.86
  • GEL $9.86
  • 52 Week High
  • ARQT $17.75
  • GEL $17.43
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 51.91
  • GEL 63.92
  • Support Level
  • ARQT $13.47
  • GEL $17.00
  • Resistance Level
  • ARQT $14.69
  • GEL $17.43
  • Average True Range (ATR)
  • ARQT 0.63
  • GEL 0.44
  • MACD
  • ARQT 0.05
  • GEL 0.01
  • Stochastic Oscillator
  • ARQT 68.53
  • GEL 84.37

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: